
KYAN Technologies is a pioneering leader in functional precision medicine for oncology, dedicated to revolutionizing cancer care through advanced technology and expertise. Their platform, Optim.AI™, empowers oncologists to personalize treatment by identifying safe and effective drug-dose combinations tailored to individual patients. By leveraging small data AI and extensive research studies, KYAN aims to enhance drug development and delivery, focusing on various cancer indications. The company is committed to providing better treatment options and has received approval from Singapore’s Ministry of Health for its clinical laboratory license, positioning itself as a key player in the biopharma industry.

KYAN Technologies is a pioneering leader in functional precision medicine for oncology, dedicated to revolutionizing cancer care through advanced technology and expertise. Their platform, Optim.AI™, empowers oncologists to personalize treatment by identifying safe and effective drug-dose combinations tailored to individual patients. By leveraging small data AI and extensive research studies, KYAN aims to enhance drug development and delivery, focusing on various cancer indications. The company is committed to providing better treatment options and has received approval from Singapore’s Ministry of Health for its clinical laboratory license, positioning itself as a key player in the biopharma industry.